Article Information
History
- April 7, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 7, 2020 - 08:03).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sovesh Mohapatra1,
- Prathul Nath1,
- Manisha Chatterjee3,*,+,
- Neeladrisingha Das4,
- Deepjyoti Kalita5,
- Partha Roy4 and
- Soumitra Satapathi1,2,*,+
- 1Department of Physics, Indian Institute of Technology, Roorkee, Haridwar, 247667, Uttarakhand, India
- 2Centre of Nanotechnology, Indian Institute of Technology, Roorkee, Haridwar, 247667, Uttarakhand, India
- 3Department of Pharmacology, Subharti Medical College Meerut, Uttar Pradesh,250002, India
- 4Department of Biotechnology, Indian Institute of Technology, Roorkee, Roorkee, 247667, Uttarakhand, India
- 5Department of Microbiology, All India Institute of Medical Science Rishikesh, 249203, Uttarakhand, India
Posted April 07, 2020.
Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking
